课题基金 / 基金详情

Regulation of the survival of mature oligodendrocytes by protein transduction of p38 MAP kinase

Regulation of the survival of mature oligodendrocytes by protein transduction of p38 MAP kinase
p38 MAP 激酶蛋白转导调节成熟少突胶质细胞的存活
批准号:
17500262
负责人:
TAKAMATSU Ken
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

TAKAMATSU Ken的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
p38 Mitogen-activated protein kinase (p38 MAPK) is expressed in the oligodendrocyte lineage, and its activity has been implicated in the proliferation and transition of early progenitors into late progenitors. Although p38 MAPK expression has been found in the myelin sheath, however, its role in mature oligodendrocytes remains unknown.In the present study, in order to address the role of p38 MAPK in mature oligodendrocytes, we analyzed 1. the expression of p38 MAPK in the mature oligodendrocytes, 2. the effects of p38 MAPK inhibition on the survival of mature oligodendrocytes, and 3. the effect of introduction of HIV-TAT-fused p38 MAPK protein on the survival of mature oligodendrocytes.1. Immunocytochemical and Western blot analysis revealed that mature oligodendrocytes express p38 MAPK, and a part of p38 MAPK is an active form. 2. The inhibition of p38 MAPK with specific inhibitors decreased the number of cultured mature oligodendrocyte by the induction of apoptosis, but did not alter the number of oligodendrocyte progenitor cells. These results indicate that p38 MAPK is essential for the mature oligodendrocyte survival. 3. The fusion proteins containing a cell-permeable TAT-peptide of human immunodeficiency virus could be efficiently introduced into mature oligodendrocyte. TAT-fusion protein with a dominant negative form of p38 MAPK caused the decrease in the number of mature oligodendrocyte, indicating the survival of mature oligodendrocyte can be directly regulated by protein transduction of TAT-p38 MAPK fusion proteins.We are investigating the mechanism of the survival of mature oligodendrocyte in vivo and in vitro using the cell permeable-TAT-p38 MAPK system.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.neuint.2007.03.005
发表时间: 2007-07-01
期刊: NEUROCHEMISTRY INTERNATIONAL
影响因子: 4.2
作者: [Hamanoue, Makoto, Sato, Kenichiro, Takamatsu, Ken]
通讯作者: Takamatsu, Ken
DOI: 10.1016/j.neuron.2007.01.011
发表时间: 2007-02-15
期刊: NEURON
影响因子: 16.2
作者: [Tzingounis, Anastassios V., Kobayashi, Masaaki, Nicoll, Roger A.]
通讯作者: Nicoll, Roger A.
Inhibition of p38 mitogen-activated protein kinase-induced apoptosis in cultured mature oligodendrocytes using SB203580.
使用 SB203580 抑制培养的成熟少突胶质细胞中 p38 丝裂原激活蛋白激酶诱导的细胞凋亡。
DOI: --
发表时间: 2007
期刊: Neurochem Int (In press)
影响因子: --
作者: [Masuo Y, et al., Hamanoue M]
通讯作者: Hamanoue M
海馬と記憶のメカニズム
海马体与记忆机制
DOI: --
发表时间: 2006
期刊: 小児科 47
影响因子: --
作者: [Masuo Y, et al., Hamanoue M, Noguchi H, 小林正明]
通讯作者: 小林正明
13
    Hippocalcin acts as a possible suppressor of neuronal apoptosis via NAIP-caspase and MLK3-JNK cascades
    • 批准号:
      13680852
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2001
    • 负责人:
      TAKAMATSU Ken
    • 依托单位:
    Biochemical and physiological assessment of neural visinin-like calcium-binding protein 3 in rodent cerebellum.
    • 批准号:
      11680764
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.56万
    • 财政年份:
      1999
    • 负责人:
      TAKAMATSU Ken
    • 依托单位:
    Molecular cloning and chromosomal localization of the genes encoding P23k neuron-specific calcium-binding protein family.
    • 批准号:
      08670733
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.22万
    • 财政年份:
      1996
    • 负责人:
      TAKAMATSU Ken
    • 依托单位:
    Molecular Cloning and Chromosomal Localization of Human Hippocalcin Gene.
    • 批准号:
      06670675
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1994
    • 负责人:
      TAKAMATSU Ken
    • 依托单位:
    海外基金